Figure 1.
AML-MRC diagnosis. (A) Percentage of cases diagnosed based on morphology, history, or MDS-associated cytogenetics. (B) Percentage distribution of MDS-associated cytogenetic abnormalities. (C) Pseudo-Pelger-Huet cell. (D) Dysplastic monolobated megakaryocytes and megakaryocytes with separated nuclear lobes. (E) Dysplastic multinucleated erythroid cell. Original magnification ×1000 for panels C-E.

AML-MRC diagnosis. (A) Percentage of cases diagnosed based on morphology, history, or MDS-associated cytogenetics. (B) Percentage distribution of MDS-associated cytogenetic abnormalities. (C) Pseudo-Pelger-Huet cell. (D) Dysplastic monolobated megakaryocytes and megakaryocytes with separated nuclear lobes. (E) Dysplastic multinucleated erythroid cell. Original magnification ×1000 for panels C-E.

Close Modal

or Create an Account

Close Modal
Close Modal